OrbiMed Capital GP VI LLC's Net Worth
$0
Who is OrbiMed Capital GP VI LLC?
OrbiMed Capital GP VI LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include resTORbio, Inc., LogicBio Therapeutics, Inc., 89bio, Inc., SteadyMed Ltd., AVEDRO INC, Turning Point Therapeutics, Inc., CONSTELLATION PHARMACEUTICALS INC, Prelude Therapeutics Inc, Crinetics Pharmaceuticals, Inc., Verona Pharma plc, ALPINE IMMUNE SCIENCES, INC., CTI BIOPHARMA CORP, NeuroPace Inc, Edgewise Therapeutics, Inc., Ikena Oncology, Inc., ARVINAS INC., Prevail Therapeutics Inc., ARS Pharmaceuticals, Inc., Disc Medicine, Inc., GRAYBUG VISION, INC., Oric Pharmaceuticals, Inc., Kala Pharmaceuticals, Inc., scPharmaceuticals Inc., NextCure, Inc., SYNLOGIC, INC., SpringWorks Therapeutics, Inc., and Turnstone Biologics Corp..
SEC CIK
OrbiMed Capital GP VI LLC's CIK is 0001682115
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
resTORbio, Inc. (ACET) Snapshot price: $1.56
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +47.01% | 3.13M |
$2.40 | $7,500,000.00 | 9.77M |
Jan 25
| |||
Form 4
| +12.10% | 875K |
$2.09 | $1,828,750.00 | 8.11M |
Jun 27
| |||
Form 4
| +765.30% | 214.28K |
$14.00 | $2,999,990.00 | 242.28K |
Dec 10
| |||
Form 4
| +10.25% | 524.35K |
$13.00 | $6,816,537.00 | 5.64M |
Feb 12
| |||
Form 4
|
∞
| 6.02M |
—
|
—
| 6.02M |
Sep 15 - Sep 17
| |||
Form 4
|
∞
| 4.83M |
$15.00 |
—
| 4.83M |
Jan 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVEDRO INC No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2,681.91% | 4.09M |
—
|
—
| 4.24M |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Turning Point Therapeutics, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.03M |
$18.00 |
—
| 2.03M |
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CONSTELLATION PHARMACEUTICALS INC No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 835.84K |
$15.00 |
—
| 835.84K |
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prelude Therapeutics Inc (PRLD) Snapshot price: $5.18
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.40% | 869.57K |
$5.75 | $4,999,998.75 | 10.12M |
May 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 27 - Aug 21
| |||
Form 4
| +4,624.95% | 9.57M |
$19.00 | $9,999,700.00 | 9.78M |
Sep 25 - Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||